No actions available.
Full Text of this Amendment
purposes; which was ordered to lie on the table; as follows:
On page 88 of the amendment, strike lines 5 through 7 and insert the following:
``(B) the packaging, repackaging, labeling, relabeling, or distribution of a prescription drug.
``(o) Prohibition on Commingling.--
``(1) IN GENERAL.--A registered importer shall not commingle a prescription drug imported into the United States under this section with another prescription drug unless such other prescription drug is imported from a permitted country.
``(2) LABEL.--A registered importer (including an Internet pharmacy) that dispenses a prescription drug imported from a permitted country shall affix on each dispensed container of the prescription drug the label required under paragraph (3), unless such a label is already affixed to the container.
``(3) REQUIREMENTS.--Each prescription drug imported under this section shall be in a container that bears a label stating, in prominent and conspicuous type--
``(A) the lot number of the prescription drug;
``(B) the name, address, and phone number of the exporter of the drug, regardless of whether the exporter is registered;
``(C) the following statement: `This drug has been imported from __XXXX.' with the name of the permitted country from which the prescription drug has imported in the blank space;
``(D) a unique identifier code provided by the Secretary that modifies the national drug code of the prescription drug to indicate that the drug has been imported;
``(E) a statement that discloses the originating country of the drug; and
``(F) that the container complies with any other applicable requirement of this Act.''.
(As printed in the Congressional Record for the Senate on May 3, 2007.)